[ Price : $8.95]
FDA clears a Visby Medical 510(k) for its point-of-care test for detecting respiratory infections caused by influenza A & B, and C...[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at Chinas Zhejiang Huahai API manufacturing facility.[ Price : $8.95]
FDA releases the form FDA-483 with six observations from an inspection at Indias Piramal Pharma API manufacturing facility.[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at Indias Indoco Remedies manufacturing facility for ster...[ Price : $8.95]
Data from an AstraZeneca interim analysis of its SERENA-6 Phase 3 breast cancer trial show that camizestrant in combination with a...[ Price : $8.95]
FDA clears a Google 510(k) for its Loss of Pulse Detection feature and its use on the Pixel Watch 3.[ Price : $8.95]
CDERs 10th yearly drug safety report highlights the FY 2024 establishment of two new units contributing to drug safety.[ Price : $8.95]
Canadian researchers find that 16% of patients in Phase 2 oncology trials receive treatments that are later approved by FDA for th...